Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York
08:01am, Tuesday, 02'nd Sep 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), today announced that it will participate in the 27th Annual H.C. Wainwright G
Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector
08:00am, Tuesday, 02'nd Sep 2025
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for i
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Tuesday, 02'nd Sep 2025
NORCROSS, Ga., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company mana
RedCloud Drives Global Expansion With Saudi Joint Venture
08:00am, Tuesday, 02'nd Sep 2025
LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”), today announces the signing of a Joint Venture with Kayanat, a family office in th
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Tuesday, 02'nd Sep 2025
MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for ne
Nasus Pharma Announces Upcoming Presentation at H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Tuesday, 02'nd Sep 2025
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd.
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Tuesday, 02'nd Sep 2025
WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the developmen
Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Tuesday, 02'nd Sep 2025
BASKING RIDGE, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative ther
electroCore to Participate at H.C. Wainwright Global Investment Conference
08:00am, Tuesday, 02'nd Sep 2025
ROCKAWAY, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at
Fundamental Global Inc.'s CEO of Digital Assets, Maja Vujinovic, to Join Anchorage Digital's Livestream on September 3, 2025
07:50am, Tuesday, 02'nd Sep 2025
Charlotte, NC, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Fundamental Global Inc (Nasdaq: FGNX, FGNXP) (the “Company” or “FG Nexus”) today announced that Maja Vujinovic, CEO of Digital Assets, will jo
Intensity Therapeutics, Inc. to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
07:47am, Tuesday, 02'nd Sep 2025
SHELTON, Conn. , Sept. 2, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and deve
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
07:30am, Tuesday, 02'nd Sep 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative
Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
07:00am, Tuesday, 02'nd Sep 2025
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
07:00am, Tuesday, 02'nd Sep 2025
WEST CHESTER, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseas
Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada's GDP in 2024
06:00am, Tuesday, 02'nd Sep 2025
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), Canada's largest cannabis company by market share, today released "High Impact, Green Growth: The Economic Footprint of Canad
